-
Published 6/1/2025
Sendaydiego X, Gold LS, Dubreuil M, Andrews JS, Reid P, Liew DFL, Goulabchand R, Hughes GC, Sparks JA, Jarvik JG, Singh S, Liew JW, Singh N. Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis. Rheumatology (Oxford). 2025 Jun 01; 64(6):3434-3443. PMID: 39936579.
-
Published 4/28/2025
Neogi T, Dubreuil M, Peloquin C, Marinko L, Camarinos J, Felson DT, Kumar D. Reply. Arthritis Rheumatol. 2025 Apr 28. PMID: 40289862.
-
Published 4/1/2025
Ferrandiz-Espadin R, Rabasa G, Gasman S, McGinley B, Stovall R, Jafarzadeh SR, Liew JW, Dubreuil M. Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis. J Rheumatol. 2025 Apr 01; 52(4):344-351. PMID: 39486857.
-
Published 3/16/2025
Neogi T, Dubreuil M, Peloquin C, Marinko L, Camarinos J, Felson DT, Kumar D. Association of Physical Therapy Care With Use of Intra-Articular Injections in People With Knee Osteoarthritis: A Real-World Cohort Study. Arthritis Rheumatol. 2025 Mar 16. PMID: 40091450.
-
Published 3/15/2025
Choufani M, Ghusn W, Dubreuil M, Ermann J. Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region. J Rheumatol. 2025 Mar 15. PMID: 40089303.